Search Results

Beaulieu was an associate professor and Canada Research Chair (Tier2) in the Department of Psychiatry Beaulieu’s research is aimed at understanding how cellular and molecular mechanisms regulated by psychoactive Translational validation is important to validate findings obtained from experimental models research In addition to basic research, the Beaulieu group is also actively implicated in translational research Jean Martin Beaulieu on the web University of Toronto Google Scholar LinkedIn ResearchGate Dr.

At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based This research stream is now forming the basis of a new technology-based start-up company, HeptOME , to

At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based This research stream is now forming the basis of a new technology-based start-up company, HeptOME , to

At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based This research stream is now forming the basis of a new technology-based start-up company, HeptOME , to

details the construction of an open-access GPCR-lipid raft database and reviews key findings from his research research, this discussion will resonate. When integrating computational predictions with real-world pharmacological readouts If you see the research Sedaghat has accumulated over two decades of teaching and research in pharmacology, contributing as a His current efforts bridge teaching in Toronto and ongoing research, including the development of an

to Webinars 📅 Tuesday, March 3, 2026 at 3:00:00 PM UTC 🤝 Webinar in collaboration with: Celtarys Research Johannes Broichhagen Group Leader Leibniz Research Institute for Molecular Pharmacology (FMP), Berlin Since 2020, he leads an independent research group at the FMP Berlin. His work carries direct translational relevance to diabetes and obesity therapeutics. research, and therapeutic development.

Our work helps biotech startups, research organizations, and CROs design operating systems that enable GPCR, we help organizations: ✅ Clarify vision and direction ✅ Translate research milestones into measurable

discovery at Glaxo (now GlaxoSmithKline) before joining UNC Chapel Hill, where he teaches and leads research discovery and development, with 25+ years of expertise and validated cell-based assays spanning basic research structured engagement opportunities for scientists and biotech leaders working across pharmacology, translational research, and therapeutic development. intelligence on GPCR drug discovery trends and developments Expert-led webinars and masterclasses with leading researchers

Deep-dive sessions focused on real pharmacology, real drug discovery challenges, and real translational feasible More than 300 recombinant mAbs against almost 200 human GPCRs, and growing Free samples for GPCR researchers Any scientist working with GPCRs — pharmacologists, medicinal chemists, cell biologists, translational researchers, discovery teams, postdocs, PIs, and industry scientists. There's no travel required, no registration fee, and you're in a room with researchers from dozens of

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and Collaborative Research and Translational Approach Arthur and Yamina from Monash University discussed GPCR researchers in Australia and the initiation of a successful series of conferences. approach to research and its capacity to translate research into therapeutic commercialization. Translating Discovery Into Clinical Application Arthur and Yamina discussed the importance of translating

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and Collaborative Research and Translational Approach Arthur and Yamina from Monash University discussed GPCR researchers in Australia and the initiation of a successful series of conferences. approach to research and its capacity to translate research into therapeutic commercialization. Translating Discovery Into Clinical Application Arthur and Yamina discussed the importance of translating

Martin Marro, currently Executive Director and Head of Cell Pharmacology at Eli Lilly’s Obesity Research career spans big pharma and biotech, encompassing functional assay development, GPCR internalization research For a deeper dive into modern GPCR research and tools, explore more episodes of the GPCR Podcast and This episode is relevant to anyone navigating the complex landscape of GPCR research and translational Researchers refining strategies for high-throughput screening or exploring biased signaling.

<< Back to podcast list Strategic Partner(s) Translating computational approaches to GPCR biologists Now in a tenure-track position, his research spans the development of computational methods such as structure-based Ricardo Capelli on the web Google Scholar ResearchGate Bysky App : @ riccardocapelli.bsky.social Twitter

Kevin Pfleger's research at the University of Western Australia sits at the intersection of assay technology , receptor pharmacology, and translational medicine. That is really why I think most people get into medical research. It's very humbling." Perkins Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Harry Perkins Institute of Medical Research Dr.

During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and Raimond Heukers , developed a nanobody platform within the research group and used this platform to develop During his Ph.D., he used these nanobodies as research tools, to investigate different GPCR conformations Starting from September 2019, Timo started working as a postdoctoral researcher at the Vrije Universiteit future, Timo hopes to combine his previous GPCR experience with his current focus to set up his own research

Each session explores mechanistic models, translational challenges, and real-world therapeutic implications ideal for: GPCR pharmacologists Medicinal chemists working on receptor targets Structural biologists Translational scientists Biotech and pharmaceutical researchers Postdoctoral fellows and graduate researchers entering These GPCR webinars focus on conceptual frameworks, models, and translational insight that apply across For researchers working in biotech, pharma, or academia, this type of continuing education can strengthen

Funded through three consecutive Wellcome Trust Senior Research Fellowships Andrew established a reputation Now at the University of Glasgow, his primary research interests are focused on the rational design of In this Andrew runs a research laboratory of around 15 staff supported by basic research grants investigating The vehicle by which Andrew is translating fundamental findings to commercial products is Keltic Pharma research.

Graeme Milligan Professor Graeme Milligan is Gardiner Professor of Biochemistry, Dean of Research, and His main research group centers on the function, structure, and regulation of G protein-coupled receptors His experience also includes translating knowledge generated into the selection of targets, screening Milligan has published more than 550 peer-reviewed articles and his research has been cited more than Graeme Milligan on the web University of Glasgow ResearchGate PubMed Orcid Google Scholar LinkedIn Dr

Industry Collaboration How do GPCR tools move from individual academic labs into broad use across the research Joining the conversation are Maria Majellaro (CSO and co-founder of Celtarys Research), Johannes Broichhagen Listeners will walk away with a clearer view of how academic innovation translates into tools for high-throughput at the CIQUS Research Center in Spain. By integrating advanced tools and translational biology, his work directly informs therapeutic strategies

Insights for GPCR researchers and functional assay innovators. << Back to podcast list Strategic Partner Laura Duvall, whose research tracks the molecular mechanisms that govern mosquito behavior, focusing This episode is essential for anyone advancing GPCR-targeted research in physiological or behavioral As a postdoctoral researcher in Leslie Vosshall’s laboratory at Rockefeller University, Dr. and translational science.

GPCR unites researchers, industry, and partners to accelerate GPCR science and drug discovery—through Our Vision A world where GPCR insights translate quickly into real‑world therapies through an open, trusted What We Do (in Three Verbs) Connect — Researchers, founders, students, and industry partners meet, learn Join To join the community, you should be actively related to the GPCR field , including: Academic researchers Partner perks: Direct interaction with researchers, founders, and decision‑makers Access to all member

Gainetdinov is the Institute of Translational Biomedicine Director at Saint Petersburg State University Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian Institute of Technology in Genova, Italy (2008-2016) and an Associate Research Professor in the Department joining the Department of Cell Biology in 1996 as a postdoc and becoming faculty at Duke in 2000, he researched Gainetdinov was included in the Web of Science (WOS) Highly Cited Researchers (HCR) list, representing

Hauser's research program asks a pointed question: if a patient fails to respond to a psychiatric drug About the Guest Alexander Hauser is a postdoctoral researcher at the University of Copenhagen's Department His research integrates GPCR molecular pharmacology, computational biology, and pharmacoepidemiology Research that bypasses clinical input tends to stay in the research community. He received the “HC Ørsted Research talent prize” and “Bayer Pharmaceuticals Ph.D.

Lauren Slosky About Irfan Dhanidina "My interest in oncology research led me to pursue a BSc in Biology GPCR research into novel therapies for patients. " Irfan Dhanidina on the web LinkedIn The Org DIBIZ Slosky’s research is focused on understanding how neuropeptide G protein-coupled receptors (GPCRs) regulate Slosky’s work has been recognized through several travel and research awards, including the William James In addition to research, Dr.

Discover how Celtarys Research is transforming GPCR assay development with fluorescent ligands in this Maria Majellaro, CSO of Celtarys Research, shares the story behind the company’s journey from academic GPCR and Celtarys, built on a shared commitment to empowering the GPCR research community. Translating Science into Business Like many scientists-turned-entrepreneurs, Maria faced the challenge Jhonny Azuaje they laid the groundwork for the future creation of Celtarys Research.

Collaborated across chemistry and biology and felt the translation gap firsthand… …this episode will His postdoctoral training included research at the École Polytechnique Fédérale de Lausanne (2015–2016 ) and later at the Max Planck Institute for Medical Research in Heidelberg, where he served as both postdoc Since 2020, JB has led his research group at the Leibniz Research Institute for Molecular Pharmacology Johannes Broichhagen on the Web LinkedIn Google Scholar Lab Website Leibniz Research Institute for Molecular

Alex Serafini shares why pain research must start with real-world behavior and models before drilling by personal experience and a desire to innovate in pain management, Alex pursued a master's in pain research “I started going through what I was going through… and that got me very interested in research.” — Alex He points out that GPCRs—especially orphan and CNS-associated ones—are often downplayed in pain research That changed everything.” — Alex Serafini Pivoting: Redefining the Pain Research Playbook Looking ahead

Why This Matters Translating basic GPCR science into actual medicines is broken. Learn in This Episode How Ajay’s failed MD/PhD application rerouted his path toward a breakthrough GPCR research Who Should Listen PhD students and postdocs exploring biotech careers GPCR scientists interested in translational Ajay’s work sits at the intersection of GPCR biology, AI, and translational medicine.

Partner(s) Lauren Solano: Mapping Careers Beyond the Bench This episode steps outside the usual GPCR research to bench scientists, ranging from medical science liaison and clinical research roles to business development Each year she delivers roughly a hundred talks at universities and research institutions on resumes, need Transferable skills in the PhD toolkit — and why they go unlisted Informational interviewing as a research Not everyone likes to do novel areas of research.

Kari Johnson's research follows this receptor from the bench to the behaving animal, using optogenetics Giving the approach a name formalizes it as a research program, not just a technique. The results have not been released to the research community. Translating GPCR Research May Require Releasing Attachment to Specific Receptors One of Johnson's more Kari Johnson on the web LinkedIn Google Scholar Research Gate USU Twitter Dr.